FocalTherics Shares Fall on Offering Price, Soft 2Q Outlook

Dow Jones

Aug 12

FocalTherics shares slid after the company priced its underwritten public offering and shared soft preliminary results for the second quarter.

The stock fell 17% to $4.98 in premarket trading Wednesday. Through the prior close, shares were up 49%.

The medical device maker said it is pricing its offering of more than 8.4 million American Depositary Shares at $4.75 apiece.

FocalTherics plans to sell all the shares and grant underwriters a 30-day option to buy up to an additional 1.3 million ADSs at the same price.

The gross proceeds are estimated to be $40 million, with the closing set for Aug. 14.

Separately, FocalTheracs said it expects to post $12.7 million to $13.2 million in revenue during the second quarter. Analysts are projecting $15.1 million in sales.

The preliminary results reflect FocalTherics' extracorporeal shock wave lithotripsy and distribution segments as discontinued operations.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2658538979"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2658538979\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2658538979?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-12 18:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2658538979","market":"sg","top_or_hot":-1,"title":"FocalTherics Shares Fall on Offering Price, Soft 2Q Outlook","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  FocalTherics shares slid after the company priced its underwritten public offering and shared soft preliminary results for the second quarter. \n</p>\n<p>\n  The stock fell 17% to $4.98 in premarket trading Wednesday. Through the prior close, shares were up 49%. \n</p>\n<p>\n  The medical device maker said it is pricing its offering of more than 8.4 million American Depositary Shares at $4.75 apiece. \n</p>\n<p>\n  FocalTherics plans to sell all the shares and grant underwriters a 30-day option to buy up to an additional 1.3 million ADSs at the same price. \n</p>\n<p>\n  The gross proceeds are estimated to be $40 million, with the closing set for Aug. 14. \n</p>\n<p>\n  Separately, FocalTheracs said it expects to post $12.7 million to $13.2 million in revenue during the second quarter. Analysts are projecting $15.1 million in sales. \n</p>\n<p>\n  The preliminary results reflect FocalTherics' extracorporeal shock wave lithotripsy and distribution segments as discontinued operations. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FocalTherics Shares Fall on Offering Price, Soft 2Q Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFocalTherics Shares Fall on Offering Price, Soft 2Q Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-08-12 18:37</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  FocalTherics shares slid after the company priced its underwritten public offering and shared soft preliminary results for the second quarter. \n</p>\n<p>\n  The stock fell 17% to $4.98 in premarket trading Wednesday. Through the prior close, shares were up 49%. \n</p>\n<p>\n  The medical device maker said it is pricing its offering of more than 8.4 million American Depositary Shares at $4.75 apiece. \n</p>\n<p>\n  FocalTherics plans to sell all the shares and grant underwriters a 30-day option to buy up to an additional 1.3 million ADSs at the same price. \n</p>\n<p>\n  The gross proceeds are estimated to be $40 million, with the closing set for Aug. 14. \n</p>\n<p>\n  Separately, FocalTheracs said it expects to post $12.7 million to $13.2 million in revenue during the second quarter. Analysts are projecting $15.1 million in sales. \n</p>\n<p>\n  The preliminary results reflect FocalTherics' extracorporeal shock wave lithotripsy and distribution segments as discontinued operations. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2658538979","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2658538979","pubTimestamp":1786531020,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"FocalTherics shares slid after the company priced its underwritten public offering and shared soft preliminary results for the second quarter.The stock fell 17% to $4.98 in premarket trading Wednesday","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","FOCL":"Edap Tms SA"},"translate_title":"FocalTherics 股价因发行价和第二季度前景疲软而下跌","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FOCL":0.9},"content_text":"FocalTherics shares slid after the company priced its underwritten public offering and shared soft preliminary results for the second quarter. \n\n\n  The stock fell 17% to $4.98 in premarket trading Wednesday. Through the prior close, shares were up 49%. \n\n\n  The medical device maker said it is pricing its offering of more than 8.4 million American Depositary Shares at $4.75 apiece. \n\n\n  FocalTherics plans to sell all the shares and grant underwriters a 30-day option to buy up to an additional 1.3 million ADSs at the same price. \n\n\n  The gross proceeds are estimated to be $40 million, with the closing set for Aug. 14. \n\n\n  Separately, FocalTheracs said it expects to post $12.7 million to $13.2 million in revenue during the second quarter. Analysts are projecting $15.1 million in sales. \n\n\n  The preliminary results reflect FocalTherics' extracorporeal shock wave lithotripsy and distribution segments as discontinued operations.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}